Biological effects of intraoperative radiation therapy: histopathological changes and immunomodulation in breast cancer patients

Intraoperative radiation therapy (IORT) delivers a single accelerated radiation dose to the breast tumor bed during breast-conserving surgery (BCS). The synergistic biologic effects of simultaneous surgery and radiation remain unclear. This study explores the cellular and molecular changes induced b...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Frontiers in immunology 2024-04, Vol.15, p.1373497
Hauptverfasser: Orozco, Javier I J, Valdez, Betsy J, Matsuba, Chikako, Simanonok, Michael P, Ensenyat-Mendez, Miquel, Ramiscal, Judi Anne B, Salomon, Matthew P, Takasumi, Yuki, Grumley, Janie G
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Intraoperative radiation therapy (IORT) delivers a single accelerated radiation dose to the breast tumor bed during breast-conserving surgery (BCS). The synergistic biologic effects of simultaneous surgery and radiation remain unclear. This study explores the cellular and molecular changes induced by IORT in the tumor microenvironment and its impact on the immune response modulation. Patients with hormone receptor (HR)-positive/HER2-negative, ductal carcinoma (DCIS), or early-stage invasive breast carcinoma undergoing BCS with margin re-excision were included. Histopathological evaluation and RNA-sequencing in the re-excision tissue were compared between patients with IORT (n=11) vs. non-IORT (n=11). Squamous metaplasia with atypia was exclusively identified in IORT specimens (63.6%, =0.004), mimicking DCIS. We then identified 1,662 differentially expressed genes (875 upregulated and 787 downregulated) between IORT and non-IORT samples. Gene ontology analyses showed that IORT was associated with the enrichment of several immune response pathways, such as inflammatory response, granulocyte activation, and T-cell activation (
ISSN:1664-3224
1664-3224
DOI:10.3389/fimmu.2024.1373497